Neurvati Neurosciences
Elliott Ruiz is a finance and operations executive with extensive experience in the healthcare and biotechnology sectors. Currently serving as Senior Vice President of Finance & Operations at Neurvati Neurosciences since April 2022, Elliott previously held the role of Treasurer & Head of Business Development Finance at Purdue Pharma L.P., where responsibilities included corporate development, capital markets, and treasury management. Prior roles include Corporate Development at Alvogen, where Elliott focused on acquisition opportunities and capital raising, and Healthcare Investment Banker at KPMG US, specializing in financial modeling and team management. Elliott's career also encompasses experience as an investment banker at Truist and Oppenheimer & Co., as well as prop trading at Opus. Educational credentials include a BA in Economics from Cornell University, an MBA from the University of Virginia Darden School of Business, and a certificate from the Executive Leadership Development Program at Yale School of Management.
This person is not in any teams
This person is not in any offices
Neurvati Neurosciences
We are neuroscience innovators. We aim to identify, acquire, and develop a collection of high-potential technologies addressing a broad range of neurological and psychiatric disorders and advance them through approval and commercialization. Our decisions to advance projects are based on fundamental analyses of the science, clinical data, regulatory path, commercial viability, and, above all else: our ability to serve patients and caregivers. As a Blackstone Life Sciences portfolio company, Neurvati is powered by best-in-class expertise, relentless passion, and deep resources to optimize the development of neuroscience therapeutics. We engage hand-picked strategic partners to broaden our reach while aligning ourselves with patient communities to enhance the development of treatments capable of transforming the lives of patients.